Search - tctmd.com

Displaying 121 - 140 of 1068

Sort: Relevancy | Date

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News NY Valves 2024

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Todd Neale

June 11, 2024

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

Presenter: Torsten P. Vahl

June 07, 2024

Presentation NY Valves 2024

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

Presenter: Omar K. Khalique

June 07, 2024

Presentation NY Valves 2024

How Serious Is the Underdiagnosis and Undertreatment Problem With Chronic AR?

Presenter: Saif Anwaruddin

June 07, 2024

Presentation NY Valves 2024

KEYNOTE LECTURE: Chronic Aortic Regurgitation – Diagnostic Challenges, Current Treatment Guidelines, and Future Directions

Presenter: Robert O. Bonow

June 07, 2024

Presentation NY Valves 2024

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Presenter: Sahar Samimi

June 07, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Presenter: Raj Makkar

June 07, 2024

Advertisement

August 2024 Dispatch for the CV Team

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Valvular Heart Disease Has a Diversity Problem

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

How Serious Is the Underdiagnosis and Undertreatment Problem With Chronic AR?

KEYNOTE LECTURE: Chronic Aortic Regurgitation – Diagnostic Challenges, Current Treatment Guidelines, and Future Directions

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content